(bupropion hydrochloride + dextromethorphan) ER
Marketedupdated 2mo agoby $AXSM Axsome Therapeutics, Inc.
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 7 investigational indications.
indications
investigational
Major Depression
all catalysts(4)
approval · 3
pdufa · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that